96-29583. Findings of Scientific Misconduct  

  • [Federal Register Volume 61, Number 224 (Tuesday, November 19, 1996)]
    [Notices]
    [Page 58883]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-29583]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Office of the Secretary
    
    
    Findings of Scientific Misconduct
    
    AGENCY: Office of the Secretary, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: Notice is hereby given that the Office of Research Integrity 
    (ORI) has made a final finding of scientific misconduct in the 
    following case:
        Eric Whitters, Ph.D., University of Oregon: Based upon an 
    investigation conducted by the University of Oregon as well as Dr. 
    Whitters' own admission, ORI found that Eric Whitters, Ph.D., former 
    postdoctoral fellow, Institute of Molecular Biology at the University 
    of Oregon, engaged in scientific misconduct by fabricating experimental 
    results that involved the selective growth of yeast strains that he 
    represented as having temperature-sensitive phenotypes. The research 
    was supported in part by a grant from the National Institute of General 
    Medical Sciences (NIGMS), National Institutes of Health (NIH).
        Dr. Whitters has accepted the ORI finding and has entered into a 
    Voluntary Exclusion Agreement with ORI in which he has voluntarily 
    agreed, for the three (3) year period beginning November 6, 1996, to 
    exclude himself from:
        (1) any contracting or subcontracting with any agency of the United 
    States Government and from eligibility for, or involvement in, 
    nonprocurement transactions (e.g., grants and cooperative agreements) 
    of the United States Government as defined in 45 CFR Part 76 (Debarment 
    Regulations), and
        (2) serving in any advisory capacity to the Public Health Service 
    (PHS), including but not limited to service on any PHS advisory 
    committee, board, and/or peer review committee, or as a consultant.
        The research at issue did not affect any published research and was 
    not included in any grant application.
    
    FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research 
    Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
    700, Rockville, MD 20852, (301) 443-5330.
    Chris B. Pascal,
    Acting Director, Office of Research Integrity.
    [FR Doc. 96-29583 Filed 11-18-96; 8:45 am]
    BILLING CODE 4160-17-P
    
    
    

Document Information

Published:
11/19/1996
Department:
Health and Human Services Department
Entry Type:
Notice
Action:
Notice.
Document Number:
96-29583
Pages:
58883-58883 (1 pages)
PDF File:
96-29583.pdf